Share Name Share Symbol Market Type Share ISIN Share Description
Amryt Pharma Plc LSE:AMYT London Ordinary Share GB00BKLTQ412 ORD 6P
  Price Change % Change Share Price Shares Traded Last Trade
  0.50 0.28% 179.50 4,159 09:00:06
Bid Price Offer Price High Price Low Price Open Price
176.00 183.00 179.50 179.00 179.00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 49.19 -56.50 -72.78 567
Last Trade Time Trade Type Trade Size Trade Price Currency
12:51:44 O 700 177.5555 GBX

Amryt Pharma (AMYT) Latest News

More Amryt Pharma News
Amryt Pharma Investors    Amryt Pharma Takeover Rumours

Amryt Pharma (AMYT) Discussions and Chat

Amryt Pharma Forums and Chat

Date Time Title Posts
23/9/202108:39Amryt Pharma6,724
04/6/202007:58Amryt Pharma14
29/9/201909:53Amryt Pharma125
22/5/201919:19AMRYT Bio-Pharma R&D12

Add a New Thread

Amryt Pharma (AMYT) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
View all Amryt Pharma trades in real-time

Amryt Pharma (AMYT) Top Chat Posts

Amryt Pharma Daily Update: Amryt Pharma Plc is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker AMYT. The last closing price for Amryt Pharma was 179p.
Amryt Pharma Plc has a 4 week average price of 155.50p and a 12 week average price of 148p.
The 1 year high share price is 228p while the 1 year low share price is currently 148p.
There are currently 316,092,197 shares in issue and the average daily traded volume is 138,723 shares. The market capitalisation of Amryt Pharma Plc is £567,385,493.62.
papillon: For the first time since March the AMYT share price rose above the Kumo (cloud) on the Ichimoku chart (which went strongly bullish yesterday). PS The closing price yesterday was 177p, not the 180p that is indicated on the chart in the header. advfn have taken the price of a small UT trade timed at 4:35pm as the closing price so don't be surprised if the AMYT share price opens at 177p on Monday morning.
papillon: Well, richpassi, the rise in the AMYT share price this morning shows that there are buyers around. The share price could really take off when the sellers on Nasdaq are finally out of stock to sell (as there is good news to come). Hopefully that will be very soon.
papillon: Yes, Adw198, AMYT is an Irish company whose main listing is on Nasdaq. AIM is just the secondary listing and has been since the Aegerion RTO. Yes, richpassi, there is no doubt the AMYT share price would be a lot higher without the Nasdaq listing. For some reason the Yanks are not enamoured with AMYT.
papillon: You did the right thing, volsung. God only knows why the AMYT share price rose earlier today as the closing price of an ADS on Nasdaq last night was equivalent to 156p per AMYT share. I sold my AMYT shares (again) earlier this month which I'd only bought back in June, for a small loss (unfortunately) and put the money into buying extra SQZ and PXC. A wise decision as it has turned out! There is obviously a reason why American investors don't rate AMYT. Is it the large debt the company has? June's recovery in the share price has all the hallmarks of a "dead cat" bounce, but why? Ray Stafford obviously thought they were cheap at £2, so why do the Yank's not agree?
papillon: Why should you find the AMYT share price fall baffling, bazworth? I find it completely logical when you consider AMYT had to pay a substantial premium to Chiasma shareholders to acquire the company. That must reduce the value of AMYT shares if Chiasma shares were already fairly valued before the takeover was announced. It's normal for the share price of the acquiring company to fall if the acquisition is of a large size relative to the acquirer and a large premium has to be paid to acquire the company.
papillon: It is jam tomorrow for AMYT shareholders, delta0091, since they haven't had much jam since AMYT first listed 5 years ago after the RTO of FAST. The original AMYT placing, 5 years ago, was at 24p. Since then we have had a 1 for 6 consolidation. Do the maths, delta0091 and you will see that AMYT has been a poor performer for long term holders. I no longer fall in love with shares. I agree the future looks bright for AMYT, but that has yet to be translated into profits for long term holders. Of course it could be worse because the AMYT share price is at least higher than it was 5 years ago, so LTH's haven't lost money.
papillon: It's always jam tomorrow with AMYT. Long term the future is bright for AMYT, but I could be dead before that bright future arrives. Consequently I sold my remaining paltry 500 AMYT shares before today's late drop in the share price I have the CVR's, so I still have skin in the game and will continue to monitor the AMYT share price and chart with a view to buying back in sometime (assuming I haven't kicked the bucket in the meantime).
papillon: I believe some yanks knew about this deal and how it would likely adversely affect the AMYT share price as the ADS price has been weak recently, especially yesterday. This weakness turned the AMYT share price and ADS Ichimoku charts strongly bearish recently.
ultrasharp: We have to face facts. There is no enthusiasm for AMYT on Nasdaq despite a stream of good news since the listing on Nasdaq in July. We saw the negative impact Nasdaq had on the AMYT share price back on the 9th September after the good news RNS had propelled the AMYT share price upwards on AIM. I'm firmly of the opinion that the AMYT share price would now be close to 300p, instead of the current 205p, if AMYT hadn't listed on Nasdaq bearing in mind the very positive RNS newsflow since 9th September. I can only assume that American investors bad memories of Aegerion and Novelion has soured their enthusiasm for AMYT. ATB PAPILLON
ultrasharp: If the AMYT share price doesn't respond positively to Thursday's Q2 figures I'm tempted to give up in disgust because the AMYT share price seems incapable of rising, especially on Nasdaq, in response to good news. ATB PAPILLON
Amryt Pharma share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
Amryt Phar..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210924 18:51:59